|
000
| 01676nam 2200373zi 4500 |
|---|
| 001 | 9.930087 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240103091659 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 231108e202401 onc ob f000 0 eng d |
|---|
| 020 | |a9780660687360 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-267/2024E-PDF |
|---|
| 245 | 00|aGuidance document : |bmaster files (MFs) - procedures and administrative requirements. |
|---|
| 246 | 17|aMaster files – procedures and administrative requirements |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |cJanuary 2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (46 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : fiches maîtresses (FMs) - procédures et exigences administratives. |
|---|
| 500 | |a"Date adopted 2008-08-08. Effective date 2024-01-02. Revised date 2024-01-02." |
|---|
| 504 | |aIncludes bibliographical references (pages 38-40). |
|---|
| 650 | 0|aPharmaceutical policy|zCanada. |
|---|
| 650 | 0|aDrug approval|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice : |w(CaOODSP)9.930090 |
|---|
| 795 | |tGuidance document : |w9.923972 |
|---|
| 856 | 40|qPDF|s655 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-267-2024-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/master-files-procedures-administrative-requirements.html |
|---|